Drug discovery has long relied on two key strategies: target-based and phenotypic screening. Recombinant technologies and genomics opened the door to modern target-based drug discovery (TBDD), ...
Digital innovation must bring down healthcare costs, the American Hospital Association’s incoming board chair said. EHRs added expenses and “didn’t connect our clinicians to the patients,” Marc Boom, ...
Curve launched Resupply in April, positively affecting its Total Value Locked (TVL). LlamaLend has received positive attention because of its soft liquidation mechanism. Curve founder Michael Egorov ...